Expert advice for Zavedos Capsule
Inform your doctor if you have or have had heart disease or any gastrointestinal disorders. Men are advised to follow contraceptive measures for at least 3 months after completion of treatment with idarubicin. Vaccination with a live vaccine should be avoided. Liver and kidney function should be evaluated with conventional clinical laboratory tests (using serum bilirubin and serum creatinine as indicators) prior to, and during treatment. Blood uric acid levels, potassium, calcium phosphate, and creatinine should be evaluated after initial treatment. Idarubicin can cause dizziness and, therefore, caution has to be taken before operating an automobile or machinery or engaging in activities requiring mental alertness and coordination.
|
Composition
|
Idarubicin (10mg) |
|
Potentially Unsafe With
|
Lactation |
|
Side Effect
|
Common
Nausea, Vomiting, Low blood platelets, Headache, Decreased white blood cell count, Hair loss, Fever, Anemia (low number of red blood cells), Chills, Diarrhoea, Stomatitis (Inflammation of the mouth), Mucosal inflammation, Burning sensation, Decreased appetite, Decreased white blood cell count (neutrophils). |
|
How to works
|
How Zavedos Capsule works
Idarubicin is an anti-cancer drug belonging to a class of medication called anthracyclines. It works by slowing or stopping the replication of cancer cells thereby inhibiting the growth of cancerous tissue.
. |
